Glomerulonephritis, Poststreptococcal Clinical Presentation

  • Author: Duvuru Geetha, MD, MRCP; Chief Editor: Vecihi Batuman, MD, FACP, FASN   more...
 
Updated: Apr 13, 2010
 

History

A history suggestive of preceding streptococcal infection may include a preceding infective episode such as pharyngitis, tonsillitis, or pyoderma. This is the sine qua non for the diagnosis of APSGN.

  • Latent period
    • A latent period always occurs between the streptococcal infection and the onset of signs and symptoms of acute glomerulonephritis.
    • In general, the latent period is 1-2 weeks after a throat infection and 3-6 weeks after a skin infection.
    • The onset of signs and symptoms at the same time as pharyngitis (also called synpharyngitic nephritis) is more likely to be immunoglobulin A (IgA) nephropathy rather than APSGN.
  • Dark urine (brown-, tea-, or cola-colored)
    • This is often the first clinical symptom.
    • Dark urine is caused by hemolysis of red blood cells that have penetrated the glomerular basement membrane and have passed into the tubular system.
  • Periorbital edema
    • The onset of puffiness of the face or eyelids is sudden. It is usually prominent upon awakening and, if the patient is active, tends to subside at the end of the day.
    • In some cases, generalized edema and other features of circulatory congestion, such as dyspnea, may be present.
    • Edema is a result of a defect in renal excretion of salt and water.
    • The severity of edema is often disproportionate to the degree of renal impairment.
  • Nonspecific symptoms
    • These can include general malaise, weakness, and anorexia and are present in 50% of patients.
    • Approximately 15% of patients complain of nausea and vomiting.
Next

Physical

  • Acute nephritic syndrome
    • Acute nephritic syndrome presenting as edema, hematuria, and hypertension with or without oliguria is the most frequent presentation of APSGN.
    • Approximately 95% of clinical cases have at least 2 manifestations, and 40% have the full-blown acute nephritic syndrome.
  • Edema
    • Edema is present in 80-90% of cases, and it is the presenting complaint in 60% of cases.
    • Compromised intraglomerular blood flow due to glomerular hypercellularity results in progressive encroachment on the cross-sectional area of the glomerular capillaries.
    • This leads to reduced blood flow that manifests as low fractional excretion of sodium and concentrated urine. This salt and water retention leads to edema.
  • Hypertension
    • Hypertension occurs in 60-80% of cases and is more common among elderly individuals.
    • In 50% of cases, the hypertension can be severe; however, more often it is transient, with normalization of blood pressure upon restoration of the glomerular filtration rate, loss of edema, and normalization of plasma volume.
    • If hypertension persists, it is more indicative of the progression to a more chronic stage or that the disease is not poststreptococcal glomerulonephritis.
    • Hypertension is thought to be the result of excessive salt and water retention.
    • Despite excessive sodium retention, the plasma levels of atrial natriuretic peptide are increased. In this condition, this suggests that the kidneys are unresponsive to atrial natriuretic peptide.
    • Plasma renin activity is usually low, and studies by Parra et al have shown that an inhibition of angiotensin-converting enzyme could be an effective short-term treatment for this low-renin hypertension.[8]
    • Hypertensive encephalopathy occurs in no more than 5-10% of patients. Usually, clinical improvement occurs without any neurological sequelae.
  • Oliguria
    • This is present in 10-50% of cases, and, in 15%, urine output is less than 200 mL.
    • Oliguria is indicative of the severe crescentic form of the disease.
    • It is often transient, with diuresis occurring within 1-2 weeks.
  • Hematuria
    • This is present universally.
    • In 30% of cases, gross hematuria is present.
  • Left ventricular dysfunction
    • Left ventricular dysfunction with or without hypertension or pericardial effusion may be present during the acute congestive and convalescent phases.
    • In rare cases, persons with APSGN can show signs of pulmonary hemorrhage.
    • In a study of 28 pediatric patients with APSGN, Taskesen et al found that on clinic admission, the plasma levels of NT-proBNP (an N-terminal peptide left over when the prohormone for brain natriuretic peptide [proBNP] is cleaved to produce active BNP) were higher in these patients than in the 26 healthy children making up the control group.[9] Moreover, the NT-proBNP levels were significantly higher in 6 patients with APSGN who were found to have left ventricular dysfunction than they were in the patients with APSGN in whom no ventricular dysfunction was diagnosed. The authors suggested that in some patients with APSGN, determination of NT-proBNP levels may prove helpful in the assessment of left ventricular volume overload and cardiac function.
Previous
Next

Causes

  • Poststreptococcal glomerulonephritis follows infection with only certain strains of streptococci designated as nephritogenic.
  • The offending organisms are virtually always group A streptococci.
  • APSGN follows pyodermatitis with streptococci M types 47, 49, 55, 2, 60, and 57 and throat infection with streptococci M types 1, 2, 4, 3, 25, 49, and 12.
Previous
 
 
Contributor Information and Disclosures
Author

Duvuru Geetha, MD, MRCP  Assistant Professor of Medicine, Department of Renal Medicine, Bayview Medical Center, Johns Hopkins University

Duvuru Geetha, MD, MRCP is a member of the following medical societies: American Society of Nephrology and International Society of Nephrology

Disclosure: Nothing to disclose.

Specialty Editor Board

Chike Magnus Nzerue, MD  Associate Dean for Clinical Affairs, Vice-Chairman of Internal Medicine, Meharry Medical College

Chike Magnus Nzerue, MD is a member of the following medical societies: American Association for the Advancement of Science, American College of Physicians, American College of Physicians-American Society of Internal Medicine, American Society of Nephrology, and National Kidney Foundation

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD  Senior Pharmacy Editor, eMedicine

Disclosure: eMedicine Salary Employment

Ajay K Singh, MB, MRCP, MBA  Associate Professor of Medicine, Harvard Medical School; Clinical Chief, Renal Division, Director of Dialysis, Brigham and Women's Hospital; Consulting Staff, Faulkner Hospital

Disclosure: Nothing to disclose.

Rebecca J Schmidt, DO, FACP, FASN  Professor of Medicine, Section Chief, Department of Medicine, Section of Nephrology, West Virginia University School of Medicine

Rebecca J Schmidt, DO, FACP, FASN is a member of the following medical societies: American College of Physicians, American Medical Association, American Society of Nephrology, International Society of Nephrology, National Kidney Foundation, Renal Physicians Association, and West Virginia State Medical Association

Disclosure: Abbott Grant/research funds Speaking and teaching; AMAG Honoraria Speaking and teaching; Amgen Honoraria Speaking and teaching; Ortho Biotech Honoraria Speaking and teaching; Renal Ventures Ownership interest Other

Chief Editor

Vecihi Batuman, MD, FACP, FASN  Professor of Medicine, Section of Nephrology-Hypertension, Tulane University School of Medicine; Chief, Medicine Service, Southeast Louisiana Veterans Health Care System

Vecihi Batuman, MD, FACP, FASN is a member of the following medical societies: American College of Physicians, American Society of Hypertension, American Society of Nephrology, and International Society of Nephrology

Disclosure: Nothing to disclose.

References
  1. Zegers RH, Weigl A, Steptoe A. The death of Wolfgang Amadeus Mozart: an epidemiologic perspective. Ann Intern Med. Aug 18 2009;151(4):274-8, W96-7. [Medline].

  2. Rodriguez-Iturbe B, Musser JM. The current state of poststreptococcal glomerulonephritis. J Am Soc Nephrol. Oct 2008;19(10):1855-64. [Medline].

  3. Ahn SY, Ingulli E. Acute poststreptococcal glomerulonephritis: an update. Curr Opin Pediatr. Apr 2008;20(2):157-62. [Medline].

  4. Wu SH, Liao PY, Yin PL, Zhang YM, Dong L. Elevated expressions of 15-lipoxygenase and lipoxin A4 in children with acute poststreptococcal glomerulonephritis. Am J Pathol. Jan 2009;174(1):115-22. [Medline]. [Full Text].

  5. Oda T, Tamura K, Yoshizawa N, et al. Elevated urinary plasmin activity resistant to alpha2-antiplasmin in acute poststreptococcal glomerulonephritis. Nephrol Dial Transplant. Jul 2008;23(7):2254-9. [Medline].

  6. Bakr A, Mahmoud LA, Al-Chenawi F, et al. HLA-DRB1* alleles in Egyptian children with post-streptococcal acute glomerulonephritis. Pediatr Nephrol. Mar 2007;22(3):376-9. [Medline].

  7. Ilyas M, Tolaymat A. Changing epidemiology of acute post-streptococcal glomerulonephritis in Northeast Florida: a comparative study. Pediatr Nephrol. Jul 2008;23(7):1101-6. [Medline].

  8. Parra G, Rodriguez-Iturbe B, Batsford S, et al. Antibody to streptococcal zymogen in the serum of patients with acute glomerulonephritis: a multicentric study. Kidney Int. Aug 1998;54(2):509-17. [Medline].

  9. Taskesen M, Taskesen T, Katar S, et al. Elevated plasma levels of N-terminal pro-brain natriuretic peptide in children with acute poststreptococcal glomerulonephritis. Tohoku J Exp Med. Apr 2009;217(4):295-8. [Medline]. [Full Text].

  10. Sorger K, Gessler U, Hubner FK, et al. Subtypes of acute postinfectious glomerulonephritis. Synopsis of clinical and pathological features. Clin Nephrol. Mar 1982;17(3):114-28. [Medline].

  11. Batsford SR, Mezzano S, Mihatsch M, et al. Is the nephritogenic antigen in post-streptococcal glomerulonephritis pyrogenic exotoxin B (SPE B) or GAPDH?. Kidney Int. Sep 2005;68(3):1120-9. [Medline].

  12. Dedeoglu IO, Springate JE, Waz WR, et al. Prolonged hypocomplementemia in poststreptococcal acute glomerulonephritis. Clin Nephrol. Nov 1996;46(5):302-5. [Medline].

  13. Deen WM, Bridges CR, Brenner BM. Biophysical basis of glomerular permselectivity. J Membr Biol. 1983;71(1-2):1-10. [Medline].

  14. Dorrington KJ, Tanford C. Molecular size and conformation of immunoglobulins. Adv Immunol. 1970;12:333-81. [Medline].

  15. Massry SG, Glassock RJ. Glomerulonephritis associated with infection. In: Massry SG, Glasscock RJ, eds. Textbook of Nephrology. 3rd ed. Baltimore, Md: Williams & Wilkins; 1995:698-703.

  16. Rodriguez-Iturbe B. Postinfectious glomerulonephritis. Am J Kidney Dis. Jan 2000;35(1):XLVI-XLVIII. [Medline].

  17. Shrier RW, Gottschalk CW, eds. Diseases of the Kidney. Vol 2. 6th ed. Boston, Mass: Little, Brown & Company; 1997:1579- 84.

  18. Silva FG. Acute postinfectious glomerulonephritis and glomerulonephritis complicating persistent bacterial infection. In: Jennette JC, Olson JL, Schwartz MM, eds. Heptinstall's Pathology of the Kidney. Vol 1. 5th ed. Philadelphia, Pa: Lippincott-Raven; 1998:389-455.

  19. Wiwanitkit V. Why is acute post-streptococcal glomerulonephritis more common in the pediatric population?. Clin Exp Nephrol. Jun 2006;10(2):164. [Medline].

Previous
Next
 
Diagram of a nephron.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.